Jabra Enhance Select 50R vs JLab Hear OTC

The Jabra Enhance Select 50R is a premium-priced OTC hearing aid at $1,195, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This behind-the-ear device ranks #29 of 65 OTC hearing aids tested, placing it in the top 43% of its category. In our testing, the Select 50R demonstrates notable strengths in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.75 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical wear. Music streaming also performs above average at 2.8/5, though this remains mixed in absolute terms. The device shows limitations in challenging listening situations. Speech in noise scores just 1.0/5, falling 0.48 points below the category average—a meaningful weakness for those who frequently encounter noisy environments. Own-voice comfort is mixed at 2.5/5, essentially matching the category average. At this price point, shoppers should note that several competitors deliver stronger overall performance. The Jabra Enhance Select 500 scores 4.16/5, while the Lucid Tala and Audicus Omni 2 both exceed 4.5/5. For those prioritizing value, devices like the Sony CRE-C20 offer similar sound performance at lower prices. The Select 50R is best suited for users who primarily need help hearing in quieter settings and value Jabra's ecosystem and reliable feedback control.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.